Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases

19 Jun 2019

Abstract excerpt

AIMS: In the search for blood-based biomarkers of neurodegenerative diseases, we characterized the concentration of total prion protein (t-PrP) in the plasma of neurodegenerative dementias. We aimed to assess its accuracy in this differential diagnostic context. METHODS: Plasma t-PrP was measured in 520 individuals including healthy controls (HC) and patients diagnosed with neurological disease control (ND),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyotrophic Lateral Sclerosis Research
Share to Prion Diseases and Protein Misfolding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31216593
DOI: 10.1111/nan.12573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseasesPMID 31216593Read ↗

Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.Semantic proximity Read ↗

Evaluation of α‐synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesSemantic proximity Read ↗

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion diseaseSemantic proximity Read ↗

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion diseaseSemantic proximity Read ↗

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseasesSemantic proximity Read ↗

Prion protein quantification in cerebrospinal fluid as a tool for prion disease drug developmentSemantic proximity Read ↗

Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesSemantic proximity Read ↗

Prions mediated neurodegenerative disorders.Semantic proximity Read ↗

Sporadic human prion diseases: molecular insights and diagnosis.Semantic proximity Read ↗

PrP concentration in the central nervous system: regional variability, genotypic effects, and pharmacodynamic impactSemantic proximity Read ↗

Genetic PrP Prion Diseases.Semantic proximity Read ↗

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.